SMTL ID : 5clm.1

1,4-Oxazine BACE1 inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.61 Å

Oligo State

monomer

Ligands

1 x 52K: N-{3-[(3R)-5-amino-3-methyl-3,6-dihydro-2H-1,4-oxazin-3-yl]phenyl}-5-chloropyridine-2-carboxamide(Non-covalent)

52K.1: 18 residues within 4Å: Chain A: G.27, Q.28, G.29, L.46, D.48, G.50, S.51, Y.87, F.124, I.126, W.131, I.134, D.244, S.245, G.246, T.247, T.248, A.351 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:F.124, A:W.131, A:I.134 Hydrogen bonds: A:D.244, A:G.246, A:T.247

3 x IOD: IODIDE ION(Non-functional Binders)

IOD.2: 1 residues within 4Å: Chain A: Y.67 Ligand excluded by PLIP IOD.3: 2 residues within 4Å: Chain A: R.112, E.150 Ligand excluded by PLIP IOD.4: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.5: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rombouts, F.J. et al., 1,4-Oxazine beta-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads. J.Med.Chem. (2015)

Release Date

2015-09-30

Peptides

Beta-secretase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-secretase 1